Introduction to the analysis of PET data in oncology Giampaolo TomasiEric O. Aboagye Review Paper 27 February 2013 Pages: 419 - 436
Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice Susan F. HudachekDaniel L. Gustafson Original Paper 25 April 2013 Pages: 437 - 449
A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models Federico GalvaninCarlo C. BallanFabrizio Bezzo Original Paper 04 June 2013 Pages: 451 - 467
A semi-mechanistic red blood cell survival model provides some insight into red blood cell destruction mechanisms Julia KorellStephen B. Duffull Original Paper 18 June 2013 Pages: 469 - 478
Sex related differences on valproic acid pharmacokinetics after oral single dose Manuel IbarraMarta VázquezHartmut Derendorf Original Paper 20 June 2013 Pages: 479 - 486
Model based design and analysis of phase II HIV-1 trials Dinko RekićDaniel RöshammarUlrika S. H. Simonsson Original Paper 11 July 2013 Pages: 487 - 496
Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats Christine AhlströmLambertus A. PeletierJohan Gabrielsson Original Paper 04 July 2013 Pages: 497 - 512
A new mathematical pharmacodynamic model of clonogenic cancer cell death by doxorubicin Jan LankelmaRafael Fernández LuqueBob Kooi Original Paper 18 July 2013 Pages: 513 - 525
Considerations for the prediction of survival time in pancreatic cancer based on registry data Gaurav BajajErin DombrowskyJeffrey S. Barrett Original Paper 12 July 2013 Pages: 527 - 536
Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries Xu Steven XuMahesh N. SamtaniThe Alzheimer’s Disease Neuroimaging Initiative Short Report 05 May 2013 Pages: 537 - 544